MedTech News
.................... by Andrew Celentano
MIT class project turns into an FDA-cleared treatment for tremors
Wristband device from Encora Therapeutics started as a project in 2.009, MIT’s iconic product-design class.
Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
Mendaera announced its handheld robot for needle-based procedures is now available to pair with Butterfly Network’s (NYSE:BFLY) portable, chip-based ultrasound probe, following the companies’ long-running collaboration.
Magnetic therapy headset shows improved cognitive function and mood in people with long COVID
A new study led by researchers from the Icahn School of Medicine at Mount Sinai and published in Brain Communications found that a transcranial low-amplitude magnetic field intervention delivered twice weekly into the brain through a noninvasive headset was associated with improvements in several measures of cognitive function and emotional well-being in people experiencing cognitive impairment associated with long COVID.
‘Mini-brains’ model myelin damage and regeneration, offering new tool for MS drug testing
Researchers have developed 3D “mini-brains” they hope will help speed up the search for much-needed drug treatments for multiple sclerosis (MS), an autoimmune condition affecting almost 3 million people worldwide. Their research has been published in the journal Nature Neuroscience.
Discovery explains how immune cells target DNA mutations to improve antibodies
Scientists at the Montreal Clinical Research Institute (IRCM), led by Université de Montréal medical professor Javier Di Noia, have shed light on a fundamental mystery in immunology: How do immune cells manage to concentrate a powerful mutagenic enzyme at precisely defined regions of DNA while largely sparing the rest of the genome from potentially dangerous damage?
BTL Expands EXOMIND® Platform with New FDA Clearances
MARLBOROUGH, Mass., Oct. 1, 2026 /PRNewswire/ — BTL Industries, a global leader in medical and wellness technologies, today announced expanded FDA clearances for EXOMIND®, its noninvasive brain stimulation platform.
Medtronic drug-coated balloon gets FDA breakthrough status
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
Edwards Lifesciences earned FDA approval for its Autus size-adjustable heart valve, a surgical pulmonary heart valve for pediatric patients with congenital heart disease, the company announced today.